Stereotaxis (NYSE:STXS) is the global leader in innovative robotic technologies designed to enhance minimally invasive treatment of arrhythmias and perform endovascular procedures. Stereotaxis’ technology, Robotic Magnetic Navigation (RMN), helps physicians treat patients with improved safety and precision. Robotic Magnetic Navigation systems consist of robotically controlled magnets next to the operating table. A physician performs the procedure from a computer cockpit, precisely steering a device with magnets embedded in its tip. Over 130,000 patients have been treated with Stereotaxis RMN at over 100 leading global hospitals, and the technology has been referenced by more than 400 scientific publications.